Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$430M |
| 3 |
Verizon
VZ
|
+$390M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Broadcom
AVGO
|
+$212M |
Top Sells
| 1 |
iShares MBS ETF
MBB
|
+$560M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$537M |
| 3 |
Financial Select Sector SPDR Fund
XLF
|
+$144M |
| 4 |
Oracle
ORCL
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| 1 | Technology | 20.19% |
| 2 | Financials | 13.06% |
| 3 | Healthcare | 12.04% |
| 4 | Consumer Discretionary | 10.99% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EAR
2501
DELISTED
Eargo, Inc. Common Stock
EAR
| $3.63M | ﹤0.01% |
4,552
+1,300
| +40% | +$1.04M |
|
2502
Anavex Life Sciences
AVXL
$805M
| $3.63M | ﹤0.01% |
158,853
+10,214
| +7% | +$234K |
|
2503
TrueCar
TRUE
$215M
| $3.63M | ﹤0.01% |
642,603
-26,246
| -4% | -$148K |
|
2504
Phathom Pharmaceuticals
PHAT
$840M
| $3.63M | ﹤0.01% |
107,120
+19,864
| +23% | +$673K |
|
2505
Talos Energy
TALO
$1.68B
| $3.62M | ﹤0.01% |
231,326
+52,438
| +29% | +$820K |
|
|
FSP
2506
Franklin Street Properties
FSP
$174M
| $3.6M | ﹤0.01% |
684,772
-76,993
| -10% | -$405K |
|
|
VAPO
2507
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $3.6M | ﹤0.01% |
19,005
+1,062
| +6% | +$201K |
|
2508
Mercado Libre
MELI
$119B
| $3.59M | ﹤0.01% |
2,307
-38
| -2% | -$59.2K |
|
|
NGM
2509
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $3.59M | ﹤0.01% |
182,110
+18,137
| +11% | +$358K |
|
|
SFT
2510
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
| $3.58M | ﹤0.01% |
41,708
+14,634
| +54% | +$1.26M |
|
|
NPTN
2511
DELISTED
NEOPHOTONICS CORP
NPTN
| $3.58M | ﹤0.01% |
350,216
-50,079
| -13% | -$511K |
|
2512
Stratasys
SSYS
$835M
| $3.57M | ﹤0.01% |
137,931
+13,775
| +11% | +$356K |
|
|
FRTA
2513
DELISTED
Forterra, Inc
FRTA
| $3.57M | ﹤0.01% |
151,607
+2,674
| +2% | +$62.9K |
|
2514
Ocular Therapeutix
OCUL
$2.23B
| $3.54M | ﹤0.01% |
249,425
+7,128
| +3% | +$101K |
|
2515
Immunovant
IMVT
$2.82B
| $3.54M | ﹤0.01% |
334,436
+2,949
| +0.9% | +$31.2K |
|
2516
Avidity Biosciences
RNA
$5.76B
| $3.53M | ﹤0.01% |
142,959
-746
| -0.5% | -$18.4K |
|
2517
Invesco Short Term Treasury ETF
TBLL
$2.18B
| $3.53M | ﹤0.01% |
33,432
-6,443
| -16% | -$681K |
|
|
AUD
2518
DELISTED
Audacy, Inc.
AUD
| $3.53M | ﹤0.01% |
819,343
+15,010
| +2% | +$64.7K |
|
2519
Eos Energy Enterprises
EOSE
$2.29B
| $3.52M | ﹤0.01% |
196,126
+40,268
| +26% | +$723K |
|
2520
Forrester Research
FORR
$195M
| $3.52M | ﹤0.01% |
76,843
+1,341
| +2% | +$61.4K |
|
2521
Nuvation Bio
NUVB
$1.07B
| $3.52M | ﹤0.01% |
377,536
+82,092
| +28% | +$764K |
|
2522
Gevo
GEVO
$404M
| $3.51M | ﹤0.01% |
482,028
+413,790
| +606% | +$3.01M |
|
2523
VSE Corp
VSEC
$3.4B
| $3.5M | ﹤0.01% |
70,664
+2,345
| +3% | +$116K |
|
|
KRON
2524
DELISTED
Kronos Bio
KRON
| $3.5M | ﹤0.01% |
146,051
+50,690
| +53% | +$1.21M |
|
2525
Funko
FNKO
$182M
| $3.5M | ﹤0.01% |
164,220
+9,840
| +6% | +$209K |
|